174 related articles for article (PubMed ID: 8146182)
1. Protein S binds to and inhibits factor Xa.
Heeb MJ; Rosing J; Bakker HM; Fernandez JA; Tans G; Griffin JH
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2728-32. PubMed ID: 8146182
[TBL] [Abstract][Full Text] [Related]
2. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.
Heeb MJ; Mesters RM; Tans G; Rosing J; Griffin JH
J Biol Chem; 1993 Feb; 268(4):2872-7. PubMed ID: 8428962
[TBL] [Abstract][Full Text] [Related]
3. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
[TBL] [Abstract][Full Text] [Related]
4. Regulation of prothrombinase activity by protein S.
van 't Veer C; Butenas S; Golden NJ; Mann KG
Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
[TBL] [Abstract][Full Text] [Related]
5. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
[TBL] [Abstract][Full Text] [Related]
6. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
Hayashi T; Nishioka J; Suzuki K
Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
[TBL] [Abstract][Full Text] [Related]
8. Human protein S cleavage and inactivation by coagulation factor Xa.
Long GL; Lu D; Xie RL; Kalafatis M
J Biol Chem; 1998 May; 273(19):11521-6. PubMed ID: 9565566
[TBL] [Abstract][Full Text] [Related]
9. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin.
Taneda H; Andoh K; Nishioka J; Takeya H; Suzuki K
J Biochem; 1994 Sep; 116(3):589-97. PubMed ID: 7852276
[TBL] [Abstract][Full Text] [Related]
11. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
Mesters RM; Heeb MJ; Griffin JH
Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
[TBL] [Abstract][Full Text] [Related]
12. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
13. Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.
Deguchi H; Sinha RK; Marchese P; Ruggeri ZM; Zilberman-Rudenko J; McCarty OJT; Cohen MJ; Griffin JH
Blood; 2016 Oct; 128(14):1870-1878. PubMed ID: 27421960
[TBL] [Abstract][Full Text] [Related]
14. Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. Evidence that factor Xa binds to tumor cells independent of factor Va.
Sakai T; Kisiel W
J Biol Chem; 1990 Jun; 265(16):9105-13. PubMed ID: 2160956
[TBL] [Abstract][Full Text] [Related]
15. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
[TBL] [Abstract][Full Text] [Related]
16. Targeting of venom phospholipases: the strongly anticoagulant phospholipase A(2) from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex.
Kerns RT; Kini RM; Stefansson S; Evans HJ
Arch Biochem Biophys; 1999 Sep; 369(1):107-13. PubMed ID: 10462445
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
Krishnaswamy S; Walker RK
Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
[TBL] [Abstract][Full Text] [Related]
18. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.
Heeb MJ; Prashun D; Griffin JH; Bouma BN
FASEB J; 2009 Jul; 23(7):2244-53. PubMed ID: 19244162
[TBL] [Abstract][Full Text] [Related]
19. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
[TBL] [Abstract][Full Text] [Related]
20. Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.
Deguchi H; Guo Z; Hayat M; Pflimlin E; Lear S; Shen W; Griffin JH
J Biol Chem; 2019 Oct; 294(41):15176-15181. PubMed ID: 31481465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]